Ono Pharmaceutical Reports Q2 GAAP EPS of ¥95.60 and 11.2% Growth in Six-Month Operating Profit
Ono Pharmaceutical (OPHLF) released its second-quarter financial results, reporting a GAAP earnings per share of ¥95.60. While quarterly revenue saw a year-on-year decline of 9.6% to ¥232.5 billion, the company demonstrated improved profitability in its half-year performance. Operating profit for the six-month period rose by 11.2% year-on-year to ¥57.91 billion, with core operating profit increasing 5.1% to ¥73.63 billion. Looking ahead, the company has provided full-year consolidated financial forecasts for the fiscal year ending March 31, 2027. Ono Pharmaceutical projects total revenue of ¥455.00 billion and an operating profit of ¥94.00 billion on an IFRS basis. The results reflect a strategic focus on maintaining profitability despite fluctuations in top-line revenue.
Tickers: $BHVN
Topics: earnings report financial forecast operating profit growth revenue decline